Thermostable Bioluminescent Intercalating Dyes for Real‐Time, Integrated Nucleic Acid Amplification and Detection

Y Yosta de Stigter (Laboratory of Chemical Biology Department of Biomedical Engineering Eindhoven University of Technology Eindhoven the Netherlands) H Harmen J. van der Veer (Laboratory of Chemical Biology Department of Biomedical Engineering Eindhoven University of Technology Eindhoven the Netherlands) S Sterre de Lignie (Laboratory of Chemical Biology Department of Biomedical Engineering Eindhoven University of Technology Eindhoven the Netherlands) R Robbert J. de Haas (Department of Physical Chemistry and Soft Matter, Wageningen University and Research) R Renko de Vries (Department of Physical Chemistry and Soft Matter, Wageningen University and Research) J Joost P. H. Schoeber (Research Group Applied Natural Sciences Fontys University of Applied Sciences Eindhoven the Netherlands) A Anne J. M. Loonen (Research Group Applied Natural Sciences Fontys University of Applied Sciences Eindhoven the Netherlands) A Adriaan J. C. van den Brule (Pathologie‐DNA Lab For Molecular Diagnostics Location Jeroen Bosch Hospital ’s‐Hertogenbosch the Netherlands) M Maarten Merkx (Department of Biomedical Engineering and the Institute for Complex Molecular Systems)

Abstract

ABSTRACT Integrated nucleic acid amplification and detection methods that can be conducted at the point of care are critical to advancing infectious disease diagnostics. We previously developed luciferase‐intercalating dye conjugates (“LUMIDs”) that allow for direct detection of double‐stranded DNA (dsDNA) through a simple, ratiometric bioluminescent readout. However, their limited thermostability hampers integration with isothermal nucleic acid amplification methods that provide the specificity and sensitivity required for diagnostics. In this work, we re‐engineered LUMID to allow for one‐pot integration with loop‐mediated isothermal amplification (LAMP) and real‐time monitoring of DNA amplification. Luciferase activity and DNA binding were retained at LAMP temperatures (60°C–65°C) by employing a thermostable NanoLuc luciferase variant and an additional thermostable DNA binding protein. To enable continuous monitoring, we additionally introduced a caged luciferin substrate with esterase‐controlled release kinetics for sustained light output. These combined advances enabled one‐pot LAMP‐LUMID assays to detect cancer‐associated human papillomavirus (HPV) subtypes with attomolar sensitivity and within ∼ 30 min. Using a simple digital camera as readout, LAMP‐LUMID demonstrated robust assay performance in patient samples, showcasing its potential as a rapid and sensitive platform for molecular diagnostics that is particularly attractive for low‐resource settings.

Article Details

Volume / Issue Vol. 65, Issue 29
Published July 13, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (9)

Y

Yosta de Stigter

Laboratory of Chemical Biology Department of Biomedical Engineering Eindhoven University of Technology Eindhoven the Netherlands

H

Harmen J. van der Veer

Laboratory of Chemical Biology Department of Biomedical Engineering Eindhoven University of Technology Eindhoven the Netherlands

S

Sterre de Lignie

Laboratory of Chemical Biology Department of Biomedical Engineering Eindhoven University of Technology Eindhoven the Netherlands

R

Robbert J. de Haas

Department of Physical Chemistry and Soft Matter, Wageningen University and Research

R

Renko de Vries

Department of Physical Chemistry and Soft Matter, Wageningen University and Research

J

Joost P. H. Schoeber

Research Group Applied Natural Sciences Fontys University of Applied Sciences Eindhoven the Netherlands

A

Anne J. M. Loonen

Research Group Applied Natural Sciences Fontys University of Applied Sciences Eindhoven the Netherlands

A

Adriaan J. C. van den Brule

Pathologie‐DNA Lab For Molecular Diagnostics Location Jeroen Bosch Hospital ’s‐Hertogenbosch the Netherlands

M

Maarten Merkx

Department of Biomedical Engineering and the Institute for Complex Molecular Systems